13F Pro13F Pro

SUVRETTA CAPITAL MANAGEMENT, LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1569064
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare62.5%$3.0B
  • Technology14.5%$689.5M
  • Consumer Discretionary9.5%$452.3M
  • Financials4.9%$234.5M
  • Other3.1%$148.0M
  • Industrials2.4%$116.0M
  • Materials1.6%$78.4M
  • Communication Services1.2%$58.2M
  • Consumer Staples0.1%$6.6M

AUM History

13fpro.ai/research/fund/suvretta-capital-management-llc-1569064

Conviction and streaks

Concentrating · top 10 = 44.6%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

ARQT$ARQTConviction hold6.8% weight · held 10 quartersLEGN$LEGNConviction hold4.3% weight · held 7 quartersPVLA$PVLAConviction hold3.6% weight · held 7 quartersAVBP$AVBPConviction hold3.3% weight · held 10 quartersBNTC$BNTCConviction hold3.3% weight · held 10 quartersAVBP$AVBPAccumulating+189% shares · 9 quarters runningZURA$ZURAAccumulating+94% shares · 4 quarters runningARQT$ARQTAccumulating+19% shares · 3 quarters runningNVDA$NVDAAccumulating+49% shares · 3 quarters runningSYY$SYYAccumulating+171% shares · 3 quarters runningDHR$DHRTrimming-90% shares · 3 quarters runningJNJ$JNJTrimming-94% shares · 3 quarters runningRCUS$RCUSTrimming-8% shares · 2 quarters runningAMZN$AMZNTrimming-50% shares · 2 quarters runningAPO$APOTrimming-29% shares · 2 quarters running

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/suvretta-capital-management-llc-1569064

SUVRETTA CAPITAL MANAGEMENT, LLC 13F holdings — Q2 2026

$5.5B portfolio (+39.7% QoQ) · 96 holdings · Q2 2026 13F · top 10 are 45% of the stock portfolio

Includes $709.4M of put/call options ($709.4M puts, $0 calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $4.8B. Weights use the stock portfolio.

All holdings — SUVRETTA CAPITAL MANAGEMENT, LLC (Q2 2026)

96 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
SPY$SPYPUTSPDR S&P 500 ETF TRUST$709.4M+171%
NVDA$NVDANVIDIA CORP$144.2M+25%
EYPT$EYPTEyePoint, Inc.$118.6M—
SYY$SYYSYSCO CORP$118.0M+22%
GE$GEGENERAL ELECTRIC CO$116.0M—
IMTX$IMTXImmatics N.V.$113.4M—
MGM$MGMMGM Resorts International$111.2M+8%
META$METAMeta Platforms, Inc.$99.0M+4%
CAPR$CAPRCAPRICOR THERAPEUTICS, INC.$98.6M+7%
KURA$KURAKura Oncology, Inc.$94.1M—
GLUE$GLUEMonte Rosa Therapeutics, Inc.$85.9M-16%
AVLN$AVLNAvalyn Pharma Inc.$82.4MNew
HD$HDHOME DEPOT, INC.$79.7M+2%
HUT$HUTHut 8 Corp.$77.3MNew
COF$COFCAPITAL ONE FINANCIAL CORP$66.8M+10%

What changed in Q2 2026

Against the previous quarter's 13F: 21 new, 26 added to, 17 trimmed, 14 sold out. Share-count changes; largest moves by dollar size first.

New positions (21)

  • AVLN$AVLNAvalyn Pharma Inc.$82.4M

    first bought this quarter

  • HUT$HUTHut 8 Corp.$77.3M

    first bought this quarter

  • APH$APHAMPHENOL CORP /DE/$47.5M

    first bought this quarter

  • ROUNDHILL ETF TRUST - MEMORY ETF$44.5M

    first bought this quarter

  • CBRS$CBRSCerebras Systems Inc.$38.0M

    first bought this quarter

  • DKS$DKSDICK'S SPORTING GOODS, INC.$34.3M

    first bought this quarter

+15 more in the Excel export

Added to (26)

  • SPY$SPYPUTSPDR S&P 500 ETF TRUST+171%

    now $709.4M

  • FAETH THERAPEUTICS INC - COM NEW+5747%

    now $50.5M

  • SPOT$SPOTSpotify Technology S.A.+9155%

    now $46.7M · held 2 qtrs, 2 adds in a row

  • IFRX$IFRXInflaRx N.V.+189%

    now $51.4M · held 10+ qtrs

  • NVDA$NVDANVIDIA CORP+25%

    now $144.2M · held 7 qtrs, 3 adds in a row

  • LXEO$LXEOLexeo Therapeutics, Inc.+411%

    now $29.7M · held 3 qtrs

+20 more in the Excel export

Trimmed (17)

  • PFGC$PFGCPerformance Food Group Co-96%

    now $1.6M · held 2 qtrs

  • USFD$USFDUS Foods Holding Corp.-98%

    now $708K · held 2 qtrs

  • MLYS$MLYSMineralys Therapeutics, Inc.-89%

    now $4.7M · held 6 qtrs

  • BAC$BACBANK OF AMERICA CORP /DE/-39%

    now $45.0M · held 6 qtrs, 2 trims in a row

  • GLUE$GLUEMonte Rosa Therapeutics, Inc.-16%

    now $85.9M · held 9 qtrs

  • UNH$UNHUNITEDHEALTH GROUP INC-36%

    now $26.7M · held 10+ qtrs, 2 trims in a row

+11 more in the Excel export

Sold out (14)

  • APLS$APLSApellis Pharmaceuticals, Inc.was $141.5M

    held 6 qtrs

  • KALV$KALVKalVista Pharmaceuticals, Inc.was $96.0M

    held 9+ qtrs

  • ERAS$ERASErasca, Inc.was $55.6M

    held 8 qtrs

  • LTH$LTHLife Time Group Holdings, Inc.was $13.7M

    held 1 qtr

  • WING$WINGWingstop Inc.was $9.2M

    held 1 qtr

  • COHR$COHRCOHERENT CORP.was $7.1M

+8 more in the Excel export

Firm AUM (Form ADV): $7.9B as of 2025-12-31 · SEC IAPD

Share

Holdings by quarter

Every 13F SUVRETTA CAPITAL MANAGEMENT, LLC has filed, 39 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow SUVRETTA CAPITAL MANAGEMENT?

Q2 2026 13F filed with the SEC on Aug 14, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of SUVRETTA CAPITAL MANAGEMENT's top 20 holdings: 50/100 (our AI quality score, weighted by position size; 13 of the 20 are scored)

Top 10 since filing

-1.5%

Value-weighted move of the 10 largest stock positions

Turnover

14%

Last quarter; 55% over the last 4

Top 10 weight

45%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

68%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 96 positions worth $5.5B in its Form 13F-HR for Q2 2026 — $4.8B in common stock plus $709.4M of put/call option positions (reported at underlying notional value, not premium at risk), led by $MANE (Veradermics, Inc) at 10.8% of the equity portfolio, followed by $ARQT and $LEGN. During the quarter the fund opened 21 new positions and exited 14 — including a new stake in $AVLN and a full exit from $APLS. The portfolio is most concentrated in Healthcare (62.5% of disclosed assets). All figures are sourced directly from SUVRETTA CAPITAL MANAGEMENT, LLC’s Form 13F-HR filing with the SEC under CIK 1569064.

Funds like this

managers whose biggest positions overlap SUVRETTA CAPITAL MANAGEMENT's
INFINITUM ASSET MANAGEMENT, LLC$983.20M 13F book · 5 shared top holdingsMANEAVBPBHVNAVLNFrazier Life Sciences Management, L.P.$4.59B 13F book · 4 shared top holdingsARQTPVLAAURAGLUESiren, L.L.C.$4.94B 13F book · 5 shared top holdingsMANERCUSCRNXPVLAMYDA Advisors LLC$671.87M 13F book · 5 shared top holdingsBHVNMANEMGMARQTSimplify Asset Management Inc.$7.19B 13F book · 3 shared top holdingsBHVNBNTCEYPTBVF INC/IL$3.91B 13F book · 3 shared top holdingsPVLAKURAGLUE

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: SUVRETTA CAPITAL MANAGEMENT, LLC

13F Pro is an AI hedge fund tracker and stock research platform. For SUVRETTA CAPITAL MANAGEMENT, LLC (SEC CIK: 1569064), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in SUVRETTA CAPITAL MANAGEMENT, LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.